• 2023-01-30
    Last Updated
  • 200
    Pages

Chemotherapy Market - Forecast(2022 - 2030)

DESCRIPTION
TABLE OF CONTENT

The Chemotherapy Market accounted for US$ XX Million/Billion in the year 2022 and is expected to grow at a CAGR of XX% during the forecast period 2021 - 2030, to account for US$ XX Million/Billion in the year 2030.

Global Chemotherapy Market is segmented by region into North America, Europe, Asia-Pacific, Middle East and Africa, South and Central America. The North America regional market is expected to grow with CAGR of XX.X% and reach US$ XX Million/Billion 2015 from US$ XX Million/Billion in 2022.

The key players profiled in the Chemotherapy Market research study includes top:

ALZA Corporation, Sanofi-Aventis SA, Pfizer Inc., Paladin Labs Inc., Novartis AG (Switzerland), Takeda Pharmaceutical Company, Medimmune, LLC, EUSA Pharma, Inc., AstraZeneca PlC, OSI Pharmaceuticals, Inc., F. Hoffmann-La Roche Ltd., Progenics Pharmaceuticals, Inc., Spectrum Pharmaceuticals, Inc., Abbott Laboratories, Bristol-Myers Squibb Company, Dendreon Corporation, Cell Genesys Inc., Genentech Inc., GlaxoSmithKline PIC, Amgen Inc., Immunomedics, Inc., Indevus Pharmaceuticals Inc.

Most important types of Chemotherapy products covered in this report are:
Paclitaxel
Vincristine
Others

Most widely used downstream fields of Chemotherapy market covered in this report are:
Hospitals
Research institutes
Others

Since, the key findings in the Chemotherapy Market research reports highlight crucial progressive industry trends, it allows the companies across the value chain to develop effective long-term strategies. The clients get to understand a clear picture of the competitors and can develop strategies and modify business expansion plans accordingly. The Chemotherapy Market research reports cover thousands of global players that based on several parameters, such as company revenue, product portfolio, and geographic presence.

marketreports.info adheres to the codes of practice of the Market Research Society and Strategic and Competitive Intelligence Professionals. The following methodology has been followed for the collection and analysis of data presented in this report:

Coverage:

The objective of updating “marketreports.info” coverage is to ensure that it represents the most up-to-date vision of the industry possible. The estimated revenues of all major companies, including private and governmental, are gathered and used to prioritize coverage. Companies which are making the news, or which are of particular interest due to their innovative approach, are prioritized.

Secondary Research:

The Chemotherapy research process begins with exhaustive secondary research using internal and external sources to obtain qualitative and quantitative information relating to each Chemotherapy Market. The secondary research sources that are typically referred to include, but are not limited to:

  • Chemotherapy related Company Websites, Annual Reports, Financial Reports, Broker Reports and Investor Presentations
  • Chemotherapy Industry Trade Journals and Other Literature
  • Chemotherapy related National Government Documents, Statistical Databases and Market Reports
  • Chemotherapy related News Articles, Press Releases and Web-Casts Specific to the Companies Operating in the Market

NOTE: All the financials considered in Company Profile’s section have been standardized to US$. This has been achieved after converting the financials (for those not in US$) with respective currency exchange rates of the particular year.

Primary Research:

“marketreports.info” conducts hundreds of primary interviews a year with industry participants and commentators in order to validate its data and analysis. A typical Chemotherapy research interview fulfils the following functions:

  • Provides First-Hand Information on Chemotherapy Market Size, Market Trends, Growth Trends, Competitive Landscape and Future Outlook
  • Chemotherapy Market Validates and Strengthens Secondary Research Findings
  • Chemotherapy Market Further Develops the Analysis Team’s Expertise and Market Understanding

Primary research involves email interactions and telephone interviews for each Chemotherapy market, category, segment and sub -segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  1. Chemotherapy Industry Participants: VPs, Business Development Managers, Market Intelligence Managers and National Sales Managers
  2. Chemotherapy Outside Experts: Valuation Experts, Research Analysts and Key Opinion Leaders Specializing in the Industry
Chapter 1 Global Chemotherapy Market Overview

1.1 Introduction
1.2 Taxonomy
1.2.1 By Product Type & End User
1.2.2 By Region
1.3 Drivers for Chemotherapy Market
1.4 Restraints for Chemotherapy Market
1.5 Opportunities for Chemotherapy Market
1.6 Trends for Chemotherapy Market
1.7 COVID-19 Impact Assessment on Chemotherapy Industry
1.8 Macro-economic Factors
1.9 Regulatory Framework
1.10 Pricing Analysis by Region, 2020
1.11 Opportunity Map Analysis
1.12 Opportunity Orbits
1.13 Market Investment Feasibility Index
1.14 PEST Analysis
1.15 PORTERS Five Force Analysis
1.16 Go to Market Strategy
1.17 Value Chain Analysis
1.18 Cost Structure Analysis
1.19 Regional Market Share and BPS Analysis

Chapter 2 Global Chemotherapy Market Overview

2.1 Global Chemotherapy Market by Product Type
2.1.1 Global Chemotherapy Market Value (US$ Mn) and Volume (Units) Comparison by Product Type (2013-2029)
2.1.2 Global Chemotherapy Market Value (US$ Mn) and Volume (Units) Market Share by Product Type in 2019
2.1.3 Global Chemotherapy Market Attractiveness Analysis by Product Type, (2013-2020)
2.2 Global Chemotherapy Market by End User
2.2.1 Global Chemotherapy Market Value (US$ Mn) and Volume (Units) Comparison by End User (2013-2029)
2.2.2 Global Chemotherapy Market Value (US$ Mn) and Volume (Units) Market Share by End User in 2019
2.2.3 Global Chemotherapy Market Attractiveness Analysis by End User, (2013-2020)
2.3 Global Chemotherapy Market by Region
2.3.1 Global Chemotherapy Market Value (US$ Mn) and Volume (Units) Comparison by Region (2013-2029)
2.3.2 Global Chemotherapy Market Value (US$ Mn) and Volume (Units) Market Share by Region in 2019
2.3.3 Global Chemotherapy Market Attractiveness Analysis by Region, (2013-2020)
2.4 Global Chemotherapy Market Outlook (2013-2029)
2.4.1 Global Chemotherapy Market Value (US$ Mn) and Volume (Units) (2013-2020)
2.4.2 Global Chemotherapy Market Value (US$ Mn) and Volume (Units) (2021-2029)
2.5 Global Chemotherapy Market Value (US$ Mn) and Volume (Units) by Regions
2.5.1 Global Chemotherapy Market Value (US$ Mn) and Volume (Units) Comparison by Region (2013-2020)
2.5.2 Global Chemotherapy Market Value (US$ Mn) and Volume (Units) Comparison by Region (2021-2029)
2.6 Global Chemotherapy Market Value (US$ Mn) and Volume (Units) by Product Type
2.6.1 Global Chemotherapy Market Value (US$ Mn) and Volume (Units) Comparison by Product Type (2013-2020)
2.6.2 Global Chemotherapy Market Value (US$ Mn) and Volume (Units) Comparison by Product Type (2021-2029)
2.7 Global Chemotherapy Market Value (US$ Mn) and Volume (Units) by End User
2.7.1 Global Chemotherapy Market Value (US$ Mn) and Volume (Units) Comparison by End User (2013-2020)
2.7.2 Global Chemotherapy Market Value (US$ Mn) and Volume (Units) Comparison by End User (2021-2029)
2.8 Global Chemotherapy Market Y-o-Y Growth Rate Comparison (2014-2029)
2.8.1 Global Chemotherapy Market Y-o-Y Growth Rate by Region
2.8.2 Global Chemotherapy Market Y-o-Y Growth Rate by Product Type
2.8.3 Global Chemotherapy Market Y-o-Y Growth Rate by End User
2.9 Global Chemotherapy Market Share Comparison (2013-2029)
2.9.1 Global Chemotherapy Market Share by Region
2.9.2 Global Chemotherapy Market Share by Product Type
2.9.3 Global Chemotherapy Market Share by End User

Chapter 3 North America Chemotherapy Market Overview

3.1 North America Chemotherapy Market by Product Type
3.1.1 North America Chemotherapy Market Value (US$ Mn) and Volume (Units) Comparison by Product Type (2013-2029)
3.1.2 North America Chemotherapy Market Value (US$ Mn) and Volume (Units) Market Share by Product Type in 2019
3.1.3 North America Chemotherapy Market Attractiveness Analysis by Product Type, (2013-2020)
3.2 North America Chemotherapy Market by End User
3.2.1 North America Chemotherapy Market Value (US$ Mn) and Volume (Units) Comparison by End User (2013-2029)
3.2.2 North America Chemotherapy Market Value (US$ Mn) and Volume (Units) Market Share by End User in 2019
3.2.3 North America Chemotherapy Market Attractiveness Analysis by End User, (2013-2020)
3.3 North America Chemotherapy Market by Region
3.3.1 North America Chemotherapy Market Value (US$ Mn) and Volume (Units) Comparison by Region (2013-2029)
3.3.2 North America Chemotherapy Market Value (US$ Mn) and Volume (Units) Market Share by Region in 2019
3.3.3 North America Chemotherapy Market Attractiveness Analysis by Region, (2013-2020)
3.4 North America Chemotherapy Market Outlook (2013-2029)
3.4.1 North America Chemotherapy Market Value (US$ Mn) and Volume (Units) (2013-2020)
3.4.2 North America Chemotherapy Market Value (US$ Mn) and Volume (Units) (2021-2029)
3.5 North America Chemotherapy Market Value (US$ Mn) and Volume (Units) by Regions
3.5.1 North America Chemotherapy Market Value (US$ Mn) and Volume (Units) Comparison by Region (2013-2020)
3.5.2 North America Chemotherapy Market Value (US$ Mn) and Volume (Units) Comparison by Region (2021-2029)
3.6 North America Chemotherapy Market Value (US$ Mn) and Volume (Units) by Product Type
3.6.1 North America Chemotherapy Market Value (US$ Mn) and Volume (Units) Comparison by Product Type (2013-2020)
3.6.2 North America Chemotherapy Market Value (US$ Mn) and Volume (Units) Comparison by Product Type (2021-2029)
3.7 North America Chemotherapy Market Value (US$ Mn) and Volume (Units) by End User
3.7.1 North America Chemotherapy Market Value (US$ Mn) and Volume (Units) Comparison by End User (2013-2020)
3.7.2 North America Chemotherapy Market Value (US$ Mn) and Volume (Units) Comparison by End User (2021-2029)
3.8 North America Chemotherapy Market Y-o-Y Growth Rate Comparison (2014-2029)
3.8.1 North America Chemotherapy Market Y-o-Y Growth Rate by Region
3.8.2 North America Chemotherapy Market Y-o-Y Growth Rate by Product Type
3.8.3 North America Chemotherapy Market Y-o-Y Growth Rate by End User
3.9 North America Chemotherapy Market Share Comparison (2013-2029)
3.9.1 North America Chemotherapy Market Share by Region
3.9.2 North America Chemotherapy Market Share by Product Type
3.9.3 North America Chemotherapy Market Share by End User

Chapter 4 Europe Chemotherapy Market Overview

4.1 Europe Chemotherapy Market by Product Type
4.1.1 Europe Chemotherapy Market Value (US$ Mn) and Volume (Units) Comparison by Product Type (2013-2029)
4.1.2 Europe Chemotherapy Market Value (US$ Mn) and Volume (Units) Market Share by Product Type in 2019
4.1.3 Europe Chemotherapy Market Attractiveness Analysis by Product Type, (2013-2020)
4.2 Europe Chemotherapy Market by End User
4.2.1 Europe Chemotherapy Market Value (US$ Mn) and Volume (Units) Comparison by End User (2013-2029)
4.2.2 Europe Chemotherapy Market Value (US$ Mn) and Volume (Units) Market Share by End User in 2019
4.2.3 Europe Chemotherapy Market Attractiveness Analysis by End User, (2013-2020)
4.3 Europe Chemotherapy Market by Region
4.3.1 Europe Chemotherapy Market Value (US$ Mn) and Volume (Units) Comparison by Region (2013-2029)
4.3.2 Europe Chemotherapy Market Value (US$ Mn) and Volume (Units) Market Share by Region in 2019
4.3.3 Europe Chemotherapy Market Attractiveness Analysis by Region, (2013-2020)
4.4 Europe Chemotherapy Market Outlook (2013-2029)
4.4.1 Europe Chemotherapy Market Value (US$ Mn) and Volume (Units) (2013-2020)
4.4.2 Europe Chemotherapy Market Value (US$ Mn) and Volume (Units) (2021-2029)
4.5 Europe Chemotherapy Market Value (US$ Mn) and Volume (Units) by Regions
4.5.1 Europe Chemotherapy Market Value (US$ Mn) and Volume (Units) Comparison by Region (2013-2020)
4.5.2 Europe Chemotherapy Market Value (US$ Mn) and Volume (Units) Comparison by Region (2021-2029)
4.6 Europe Chemotherapy Market Value (US$ Mn) and Volume (Units) by Product Type
4.6.1 Europe Chemotherapy Market Value (US$ Mn) and Volume (Units) Comparison by Product Type (2013-2020)
4.6.2 Europe Chemotherapy Market Value (US$ Mn) and Volume (Units) Comparison by Product Type (2021-2029)
4.7 Europe Chemotherapy Market Value (US$ Mn) and Volume (Units) by End User
4.7.1 Europe Chemotherapy Market Value (US$ Mn) and Volume (Units) Comparison by End User (2013-2020)
4.7.2 Europe Chemotherapy Market Value (US$ Mn) and Volume (Units) Comparison by End User (2021-2029)
4.8 Europe Chemotherapy Market Y-o-Y Growth Rate Comparison (2014-2029)
4.8.1 Europe Chemotherapy Market Y-o-Y Growth Rate by Region
4.8.2 Europe Chemotherapy Market Y-o-Y Growth Rate by Product Type
4.8.3 Europe Chemotherapy Market Y-o-Y Growth Rate by End User
4.9 Europe Chemotherapy Market Share Comparison (2013-2029)
4.9.1 Europe Chemotherapy Market Share by Region
4.9.2 Europe Chemotherapy Market Share by Product Type
4.9.3 Europe Chemotherapy Market Share by End User

Chapter 5 Asia Pacific Chemotherapy Market Overview

5.1 Asia Pacific Chemotherapy Market by Product Type
5.1.1 Asia Pacific Chemotherapy Market Value (US$ Mn) and Volume (Units) Comparison by Product Type (2013-2029)
5.1.2 Asia Pacific Chemotherapy Market Value (US$ Mn) and Volume (Units) Market Share by Product Type in 2019
5.1.3 Asia Pacific Chemotherapy Market Attractiveness Analysis by Product Type, (2013-2020)
5.2 Asia Pacific Chemotherapy Market by End User
5.2.1 Asia Pacific Chemotherapy Market Value (US$ Mn) and Volume (Units) Comparison by End User (2013-2029)
5.2.2 Asia Pacific Chemotherapy Market Value (US$ Mn) and Volume (Units) Market Share by End User in 2019
5.2.3 Asia Pacific Chemotherapy Market Attractiveness Analysis by End User, (2013-2020)
5.3 Asia Pacific Chemotherapy Market by Region
5.3.1 Asia Pacific Chemotherapy Market Value (US$ Mn) and Volume (Units) Comparison by Region (2013-2029)
5.3.2 Asia Pacific Chemotherapy Market Value (US$ Mn) and Volume (Units) Market Share by Region in 2019
5.3.3 Asia Pacific Chemotherapy Market Attractiveness Analysis by Region, (2013-2020)
5.4 Asia Pacific Chemotherapy Market Outlook (2013-2029)
5.4.1 Asia Pacific Chemotherapy Market Value (US$ Mn) and Volume (Units) (2013-2020)
5.4.2 Asia Pacific Chemotherapy Market Value (US$ Mn) and Volume (Units) (2021-2029)
5.5 Asia Pacific Chemotherapy Market Value (US$ Mn) and Volume (Units) by Regions
5.5.1 Asia Pacific Chemotherapy Market Value (US$ Mn) and Volume (Units) Comparison by Region (2013-2020)
5.5.2 Asia Pacific Chemotherapy Market Value (US$ Mn) and Volume (Units) Comparison by Region (2021-2029)
5.6 Asia Pacific Chemotherapy Market Value (US$ Mn) and Volume (Units) by Product Type
5.6.1 Asia Pacific Chemotherapy Market Value (US$ Mn) and Volume (Units) Comparison by Product Type (2013-2020)
5.6.2 Asia Pacific Chemotherapy Market Value (US$ Mn) and Volume (Units) Comparison by Product Type (2021-2029)
5.7 Asia Pacific Chemotherapy Market Value (US$ Mn) and Volume (Units) by End User
5.7.1 Asia Pacific Chemotherapy Market Value (US$ Mn) and Volume (Units) Comparison by End User (2013-2020)
5.7.2 Asia Pacific Chemotherapy Market Value (US$ Mn) and Volume (Units) Comparison by End User (2021-2029)
5.8 Asia Pacific Chemotherapy Market Y-o-Y Growth Rate Comparison (2014-2029)
5.8.1 Asia Pacific Chemotherapy Market Y-o-Y Growth Rate by Region
5.8.2 Asia Pacific Chemotherapy Market Y-o-Y Growth Rate by Product Type
5.8.3 Asia Pacific Chemotherapy Market Y-o-Y Growth Rate by End User
5.9 Asia Pacific Chemotherapy Market Share Comparison (2013-2029)
5.9.1 Asia Pacific Chemotherapy Market Share by Region
5.9.2 Asia Pacific Chemotherapy Market Share by Product Type
5.9.3 Asia Pacific Chemotherapy Market Share by End User

Chapter 6 South America Chemotherapy Market Overview

6.1 South America Chemotherapy Market by Product Type
6.1.1 South America Chemotherapy Market Value (US$ Mn) and Volume (Units) Comparison by Product Type (2013-2029)
6.1.2 South America Chemotherapy Market Value (US$ Mn) and Volume (Units) Market Share by Product Type in 2019
6.1.3 South America Chemotherapy Market Attractiveness Analysis by Product Type, (2013-2020)
6.2 South America Chemotherapy Market by End User
6.2.1 South America Chemotherapy Market Value (US$ Mn) and Volume (Units) Comparison by End User (2013-2029)
6.2.2 South America Chemotherapy Market Value (US$ Mn) and Volume (Units) Market Share by End User in 2019
6.2.3 South America Chemotherapy Market Attractiveness Analysis by End User, (2013-2020)
6.3 South America Chemotherapy Market by Region
6.3.1 South America Chemotherapy Market Value (US$ Mn) and Volume (Units) Comparison by Region (2013-2029)
6.3.2 South America Chemotherapy Market Value (US$ Mn) and Volume (Units) Market Share by Region in 2019
6.3.3 South America Chemotherapy Market Attractiveness Analysis by Region, (2013-2020)
6.4 South America Chemotherapy Market Outlook (2013-2029)
6.4.1 South America Chemotherapy Market Value (US$ Mn) and Volume (Units) (2013-2020)
6.4.2 South America Chemotherapy Market Value (US$ Mn) and Volume (Units) (2021-2029)
6.5 South America Chemotherapy Market Value (US$ Mn) and Volume (Units) by Regions
6.5.1 South America Chemotherapy Market Value (US$ Mn) and Volume (Units) Comparison by Region (2013-2020)
6.5.2 South America Chemotherapy Market Value (US$ Mn) and Volume (Units) Comparison by Region (2021-2029)
6.6 South America Chemotherapy Market Value (US$ Mn) and Volume (Units) by Product Type
6.6.1 South America Chemotherapy Market Value (US$ Mn) and Volume (Units) Comparison by Product Type (2013-2020)
6.6.2 South America Chemotherapy Market Value (US$ Mn) and Volume (Units) Comparison by Product Type (2021-2029)
6.7 South America Chemotherapy Market Value (US$ Mn) and Volume (Units) by End User
6.7.1 South America Chemotherapy Market Value (US$ Mn) and Volume (Units) Comparison by End User (2013-2020)
6.7.2 South America Chemotherapy Market Value (US$ Mn) and Volume (Units) Comparison by End User (2021-2029)
6.8 South America Chemotherapy Market Y-o-Y Growth Rate Comparison (2014-2029)
6.8.1 South America Chemotherapy Market Y-o-Y Growth Rate by Region
6.8.2 South America Chemotherapy Market Y-o-Y Growth Rate by Product Type
6.8.3 South America Chemotherapy Market Y-o-Y Growth Rate by End User
6.9 South America Chemotherapy Market Share Comparison 2013-2029
6.9.1 South America Chemotherapy Market Share by Region
6.9.2 South America Chemotherapy Market Share by Product Type
6.9.3 South America Chemotherapy Market Share by End User

Chapter 7 MEA Chemotherapy Market Overview

7.1 MEA Chemotherapy Market by Product Type
7.1.1 MEA Chemotherapy Market Value (US$ Mn) and Volume (Units) Comparison by Product Type (2013-2029)
7.1.2 MEA Chemotherapy Market Value (US$ Mn) and Volume (Units) Market Share by Product Type in 2019
7.1.3 MEA Chemotherapy Market Attractiveness Analysis by Product Type, (2013-2020)
7.2 MEA Chemotherapy Market by End User
7.2.1 MEA Chemotherapy Market Value (US$ Mn) and Volume (Units) Comparison by End User (2013-2029)
7.2.2 MEA Chemotherapy Market Value (US$ Mn) and Volume (Units) Market Share by End User in 2019
7.2.3 MEA Chemotherapy Market Attractiveness Analysis by End User, (2013-2020)
7.3 MEA Chemotherapy Market by Region
7.3.1 MEA Chemotherapy Market Value (US$ Mn) and Volume (Units) Comparison by Region (2013-2029)
7.3.2 MEA Chemotherapy Market Value (US$ Mn) and Volume (Units) Market Share by Region in 2019
7.3.3 MEA Chemotherapy Market Attractiveness Analysis by Region, (2013-2020)
7.4 MEA Chemotherapy Market Outlook (2013-2029)
7.4.1 MEA Chemotherapy Market Value (US$ Mn) and Volume (Units) (2013-2020)
7.4.2 MEA Chemotherapy Market Value (US$ Mn) and Volume (Units) (2021-2029)
7.5 MEA Chemotherapy Market Value (US$ Mn) and Volume (Units) by Regions
7.5.1 MEA Chemotherapy Market Value (US$ Mn) and Volume (Units) Comparison by Region (2013-2020)
7.5.2 MEA Chemotherapy Market Value (US$ Mn) and Volume (Units) Comparison by Region (2021-2029)
7.6 MEA Chemotherapy Market Value (US$ Mn) and Volume (Units) by Product Type
7.6.1 MEA Chemotherapy Market Value (US$ Mn) and Volume (Units) Comparison by Product Type (2013-2020)
7.6.2 MEA Chemotherapy Market Value (US$ Mn) and Volume (Units) Comparison by Product Type (2021-2029)
7.7 MEA Chemotherapy Market Value (US$ Mn) and Volume (Units) by End User
7.7.1 MEA Chemotherapy Market Value (US$ Mn) and Volume (Units) Comparison by End User (2013-2020)
7.7.2 MEA Chemotherapy Market Value (US$ Mn) and Volume (Units) Comparison by End User (2021-2029)
7.8 MEA Chemotherapy Market Y-o-Y Growth Rate Comparison (2014-2029)
7.8.1 MEA Chemotherapy Market Y-o-Y Growth Rate by Region
7.8.2 MEA Chemotherapy Market Y-o-Y Growth Rate by Product Type
7.8.3 MEA Chemotherapy Market Y-o-Y Growth Rate by End User
7.9 MEA Chemotherapy Market Share Comparison (2013-2029)
7.9.1 MEA Chemotherapy Market Share by Region
7.9.2 MEA Chemotherapy Market Share by Product Type
7.9.3 MEA Chemotherapy Market Share by End User

Chapter 8 Global Chemotherapy Market Company Profiles

8.1 Market Competition Scenario Analysis, By Company
8.2 Competitor Landscape
8.3 Company Share Analysis
8.4 Company Profiles
8.4.1 Company
8.4.1.1 Company Overview
8.4.1.2 Business Description
8.4.1.3 Product Portfolio
8.4.1.4 Key Financials
8.4.1.5 Key Developments
8.4.1.6 SWOT Analysis

Companies Included:
ALZA Corporation
Sanofi-Aventis SA
Pfizer Inc.
Paladin Labs Inc.
Novartis AG (Switzerland)
Takeda Pharmaceutical Company
Medimmune, LLC
EUSA Pharma, Inc.
AstraZeneca PlC
OSI Pharmaceuticals, Inc.
F. Hoffmann-La Roche Ltd.
Progenics Pharmaceuticals, Inc.
Spectrum Pharmaceuticals, Inc.
Abbott Laboratories
Bristol-Myers Squibb Company
Dendreon Corporation
Cell Genesys Inc.
Genentech Inc.
GlaxoSmithKline PIC
Amgen Inc.
Immunomedics, Inc.
Indevus Pharmaceuticals Inc.

Chapter 9 Methodology and Data Source

9.1 Research Approach/ Methodology
9.2 Market Size Estimation
9.3 Market Breakdown and Data Triangulation
9.4 Data Source
9.4.1 Secondary Sources
9.4.2 Primary Sources

Licensing Options

One User
$3900
Enterprise User
$7800